Rare Immune Disorders
Showing 26 - 50 of >10,000
Immune System Diseases, Autoimmune Diseases, Inflammation Trial (observational cohort study)
Not yet recruiting
- Immune System Diseases
- +15 more
- observational cohort study
- (no location specified)
Jul 23, 2023
PEGylated GH for Treatment of Short Stature in Chinese
Recruiting
- Growth Hormone Treatment
- Growth Disorders
- Polyethylene glycol recombinant human growth hormone injection
-
Beijing, Beijing, ChinaDepartment of Endocrinology, Genetics, Metabolism
Sep 12, 2023
Immune Deficiency Disorders, Severe Combined Immunodeficiency, Chronic Granulomatous Disease Trial in Saint Louis (Transplant
Recruiting
- Immune Deficiency Disorders
- +13 more
- Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan
-
Saint Louis, MissouriWashington University
Apr 25, 2022
Characterize Patients Treated at Internal Medicine Clinics
Recruiting
- Respiratory Disease
- +7 more
- Inpatient or Outpatient visit
-
Milan, Italy
- +1 more
Mar 24, 2023
Mental Disorder Trial (Enhancing Your Immune Health)
Not yet recruiting
- Mental Disorder
- Enhancing Your Immune Health
- (no location specified)
Dec 2, 2022
Autoreactive B Cells in Membranous Nephropathy
Recruiting
- Membranous Nephropathy
- In vitro assays.
-
Ranica, BG, ItalyCentro di Ricerche Cliniche per le Malattie Rare " Aldo e Cele D
Nov 2, 2022
Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction
Not yet recruiting
- Hiv
- +5 more
- differences in CD4 reconstruction
- (no location specified)
Sep 17, 2023
Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Primary T-cell Immunodeficiency Disorders Trial in Bethesda,
Recruiting
- Lymphoproliferative Disorders
- +4 more
- Immunosuppression Only Conditioning
- +3 more
-
Bethesda, Maryland
- +1 more
Jan 25, 2023
Fibromyalgia, Chronic Fatigue Syndrome, Multiple Sclerosis Trial in Birmingham ([Zr-89]Oxine-labeled leukocytes PET/MRI)
Recruiting
- Fibromyalgia
- +3 more
- [Zr-89]Oxine-labeled leukocytes PET/MRI
-
Birmingham, AlabamaUAB
Dec 16, 2022
Sarcoma Trial in France (Nivolumab and IPILIMUMAB, Pazopanib Oral Tablet [Votrient])
Recruiting
- Sarcoma
- Nivolumab and IPILIMUMAB
- Pazopanib Oral Tablet [Votrient]
-
Lyon, Rhône, France
- +10 more
Jun 22, 2022
Severe Aplastic Anemia, Single Lineage Cytopenias, T-LGL, Hypoplastic MDS Trial run by the National Heart, Lung, and Blood
Not yet recruiting
- Severe Aplastic Anemia
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 23, 2023
Rare and Atypical Diabetes Network
Recruiting
- Diabetes Mellitus
- +6 more
-
Aurora, Colorado
- +13 more
Sep 14, 2022
Paroxysmal Nocturnal Hemoglobinuria Trial run by the Aplastic Anemia and MDS International Foundation
Recruiting
- Paroxysmal Nocturnal Hemoglobinuria
-
Bethesda, MarylandAplastic Anemia and MDS International Foundation
Feb 23, 2023
Participation in a Research Registry for Immune Disorders
Recruiting
- Primary Immunodeficiencies
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 7, 2022
Peripheral Immune System in Individuals With Schizophrenia
Recruiting
- Schizophrenia
- +2 more
- SCID (Standardized Clinical Interview for DSM-V)
- +7 more
-
Stanford, CaliforniaStanford University School of Medicine
Mar 15, 2022
Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,
Recruiting
- Primary Immune Deficiency Disorder
- +2 more
- Alemtuzumab
- +6 more
-
Baltimore, MarylandJohns Hopkins University
Oct 20, 2022
Resilience and Coping inRare Skeletal Disease Population to Face
Recruiting
- Multiple Osteochondroma
- +3 more
-
Bologna, ItalyIRCCS Istituto Ortopedico Rizzoli
Mar 11, 2022
Immunity Disorders, Aging, Inflammation Trial in Bainbridge Island (HTB Rejuvenate)
Completed
- Immunity Disorders
- +2 more
- HTB Rejuvenate
-
Bainbridge Island, WashingtonBig Bold Health PBC
Dec 5, 2022
Hyperferritinemia Candidate Gene
Recruiting
- Hyperferritinemia
- Genetic analysis
-
Monza, MB, ItalyCentre for Rare Disease - Disorders of Iron Metabolism, ASST-Mon
Jan 17, 2023
Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Immune System Diseases Trial run by the NCI (drug, radiation,
Recruiting
- Lymphoproliferative Disorders
- +4 more
- Busulfan test dose
- +8 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Primary Immune Regulatory Disorder, Autoimmune Lymphoproliferative, Immune System Diseases Trial in United States (Emapalumab,
Recruiting
- Primary Immune Regulatory Disorder
- +2 more
- Emapalumab
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Mar 15, 2023
Immunologic Deficiency Syndromes Trial in Canada, United States (GC5107)
Completed
- Immunologic Deficiency Syndromes
- GC5107
-
Centennial, Colorado
- +19 more
Nov 11, 2022